Summary
This retrospective observational study characterises extrapulmonary Mycobacterium abscessus complex infections in a cohort of heart transplant and ventricular assist device recipients, as suggested by the 2023 publication in the American Journal of Transplantation. The paper appears to describe the epidemiological features, clinical manifestations, antimicrobial resistance patterns, and outcomes associated with different management strategies in this immunocompromised population. The work contributes to understanding a rare but serious opportunistic infection in cardiothoracic transplant patients.
Regional applicability
This study addresses a rare opportunistic infection in specialist cardiothoracic transplant centres. Findings may be relevant to UK transplant units, though prevalence and epidemiology may differ by centre and water/environmental exposure.
Key measures
Infection incidence, clinical presentation patterns, antimicrobial susceptibility profiles, treatment regimens, patient outcomes (graft function, survival, infection resolution)
Outcomes reported
The study characterised the epidemiology, clinical presentation, and treatment outcomes of extrapulmonary Mycobacterium abscessus complex infections in heart transplant and ventricular assist device recipients. The paper likely reports infection rates, clinical manifestations, antimicrobial susceptibility patterns, and patient outcomes with different management approaches.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.